|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500105804 |
|
最近更新日期: Date of Last Refreshed on: |
2025-07-11 08:58:41 |
|
注册时间: Date of Registration: |
2025-07-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
Role of Hair Follicle Transplantation in Reconstructive and Aesthetic Surgery |
|
Public title: |
Role of Hair Follicle Transplantation in Reconstructive and Aesthetic Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
Role of Hair Follicle Transplantation in Reconstructive and Aesthetic Surgery |
|
Scientific title: |
Role of Hair Follicle Transplantation in Reconstructive and Aesthetic Surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
Mohamed Hazem Elshahidi |
研究负责人: |
Ahmed Hassam Elsabbagh |
|
Applicant: |
Mohamed Hazem Elshahidi |
Study leader: |
Ahmed Hassam Elsabbagh |
|
申请注册联系人电话: Applicant telephone: |
+20 10 63106500 |
研究负责人电话:
Study leader's |
+20 10 63106500 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
mohamedissamelshahidi@gmail.com |
研究负责人电子邮件: Study leader's E-mail: |
mohamedissamelshahidi@gmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
研究负责人通讯地址: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
|
Applicant address: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
Study leader's address: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
Mansoura University Hospital |
||
|
Applicant's institution: |
Mansoura University Hospital |
||
|
研究负责人所在单位: |
Mansoura University Hospital |
||
|
Affiliation of the Leader: |
Mansoura University Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
MS.24.12.3020 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
Medical Research Ethics Committee IRB Mansoura Faculty of Medicine University |
||
|
Name of the ethic committee: |
Medical Research Ethics Committee IRB Mansoura Faculty of Medicine University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-02 00:00:00 | ||
|
伦理委员会联系人: |
Mansoura IRB |
||
|
Contact Name of the ethic committee: |
Mansoura IRB |
||
|
伦理委员会联系地址: |
Mansoura Facutly of Medicine, Mansoura, Dakahlia, Egypt |
||
|
Contact Address of the ethic committee: |
Mansoura Facutly of Medicine, Mansoura, Dakahlia, Egypt |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+20 10 92127930 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
Mansoura University Hospital |
||||||||||||||||||||||
|
Primary sponsor: |
Mansoura University Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
||||||||||||||||||||||
|
Primary sponsor's address: |
Mansoura University Hospitals, Mansoura, Dakahlia, Egypt |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
Self-funded |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
研究疾病: |
Chronic ulcer, chronic scars |
||||||||||||||||||||||
|
Target disease: |
Chronic ulcer, chronic scars |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
To study the clinical efficacy of HFU transplantation into chronic wounds comparing it with phase-appropriate wound care such as skin grafting. Also, the aesthetic outcome of HFU transplantation into scars will be investigated and the role of prior nano-fat injection will be studied. |
||||||||||||||||||||||
|
Objectives of Study: |
To study the clinical efficacy of HFU transplantation into chronic wounds comparing it with phase-appropriate wound care such as skin grafting. Also, the aesthetic outcome of HFU transplantation into scars will be investigated and the role of prior nano-fat injection will be studied. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. Chronic ulcers for more than 3 months not responding to the usual phase-appropriate wound care 2. Ulcers of vascular or diabetic origin 3. Ulcers in the lower limbs 4. Ulcer size > 1 cm^2 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Chronic ulcers for more than 3 months not responding to the usual phase-appropriate wound care 2. Ulcers of vascular or diabetic origin 3. Ulcers in the lower limbs 4. Ulcer size > 1 cm^2 |
||||||||||||||||||||||
|
排除标准: |
1. Ulcers due to vasculitis, radiation, pressure or other inflammatory pathologies. 2. Patients with poor control of the underlying aetiology of the lesion 3. Poor patient compliance 5. Patient on immunosuppressive drugs or on steroids 6. Patient with coagulopathy 7. Patient deemed unfit for surgery by anaesthesia consultation 8. Patients with peripheral arterial diseases 9. Pregnancy |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Ulcers due to vasculitis, radiation, pressure or other inflammatory pathologies. 2. Patients with poor control of the underlying aetiology of the lesion 3. Poor patient compliance 5. Patient on immunosuppressive drugs or on steroids 6. Patient with coagulopathy 7. Patient deemed unfit for surgery by anaesthesia consultation 8. Patients with peripheral arterial diseases 9. Pregnancy |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-01-01 00:00:00至 To 2026-01-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-08-01 00:00:00 至 To 2026-01-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
None |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
IPD can be shard by contacting the principal investigator. |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
IPD can be shard by contacting the principal investigator. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
Case Record Form |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |